Tags

Type your tag names separated by a space and hit enter

Methodological aspects of oxygen gradient ektacytometry in sickle cell disease: Effects of sample storage on outcome parameters in distinct patient subgroups.
Clin Hemorheol Microcirc. 2021; 77(4):391-394.CH

Abstract

Sickle cell disease (SCD) is a genetic disorder characterized by the production of an abnormal hemoglobin (Hb), which, under deoxygenation, may polymerize and cause a mechanical distortion of red blood cell (RBC) into a crescent-like shape. Recently a method, using ektacytometry principle, has been developed to assess RBC deformability as a function of oxygen tension (pO2) and is called oxygen gradient ektacytometry (oxygenscan). However, standardization of this test is needed to properly assess the tendency of sickling of RBCs under deoxygenation and to allow comparisons between different laboratories. The study compared the oxygenscan responses during blood storage between distinct populations of SCD patients. Blood from 40 non-transfused homozygous SCD patients (HbSS), 16 chronically transfused HbSS patients, and 14 individuals with compound heterozygous hemoglobin SC disease (HbSC) at steady-state was collected in EDTA tubes. Measurements were performed within 4 hours after collection and after 24 hours of storage at 4°C. We showed that storage affected the minimum RBC deformability reached during deoxygenation (EImin) in both non-transfused HbSS and HbSC patients and the maximum RBC deformability (EImax) measured before deoxygenation (i.e., in normoxia) in the three groups. In contrast, the tendency of RBCs to sickle under deoxygenation (i.e., the point of sickling; PoS) remained rather stable between the two time of measurements. Collectively, since the time between blood sampling and analysis affects some key oxygen gradient ektacytometry-derived parameters we recommend that each laboratory performs oxygenscan measurements at a standardized time point.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Boisson C
"Vascular Biology and Red Blood Cell" Team, Laboratory LIBM EA7424, University of Lyon 1, Lyon, France. Laboratory of Excellence GR-Ex, Paris, France.
Rab MAE
Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Van Creveldkliniek,University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Nader E
"Vascular Biology and Red Blood Cell" Team, Laboratory LIBM EA7424, University of Lyon 1, Lyon, France. Laboratory of Excellence GR-Ex, Paris, France.
Renoux C
"Vascular Biology and Red Blood Cell" Team, Laboratory LIBM EA7424, University of Lyon 1, Lyon, France. Laboratory of Excellence GR-Ex, Paris, France. Laboratory of Biochemistry and Molecular Biology, UF Biochemistry of Red Blood Cell Diseases, Est Center of Biology and Pathology, Hospices Civils de Lyon, Lyon, France.
van Oirschot BA
Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Joly P
"Vascular Biology and Red Blood Cell" Team, Laboratory LIBM EA7424, University of Lyon 1, Lyon, France. Laboratory of Excellence GR-Ex, Paris, France. Laboratory of Biochemistry and Molecular Biology, UF Biochemistry of Red Blood Cell Diseases, Est Center of Biology and Pathology, Hospices Civils de Lyon, Lyon, France.
Fort R
Department of Internal Medicine, Hospices Civils de Lyon, Lyon, France.
Stauffer E
Department of Functional Respiratory Investigations, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.
van Beers EJ
Van Creveldkliniek,University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Sheehan VA
Department of Pediatrics, Emory University, Atlanta, GA, USA.
van Wijk R
Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Connes P
"Vascular Biology and Red Blood Cell" Team, Laboratory LIBM EA7424, University of Lyon 1, Lyon, France. Laboratory of Excellence GR-Ex, Paris, France.

MeSH

Anemia, Sickle CellErythrocyte DeformabilityFemaleHumansMaleOxygen

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33361587

Citation

Boisson, Camille, et al. "Methodological Aspects of Oxygen Gradient Ektacytometry in Sickle Cell Disease: Effects of Sample Storage On Outcome Parameters in Distinct Patient Subgroups." Clinical Hemorheology and Microcirculation, vol. 77, no. 4, 2021, pp. 391-394.
Boisson C, Rab MAE, Nader E, et al. Methodological aspects of oxygen gradient ektacytometry in sickle cell disease: Effects of sample storage on outcome parameters in distinct patient subgroups. Clin Hemorheol Microcirc. 2021;77(4):391-394.
Boisson, C., Rab, M. A. E., Nader, E., Renoux, C., van Oirschot, B. A., Joly, P., Fort, R., Stauffer, E., van Beers, E. J., Sheehan, V. A., van Wijk, R., & Connes, P. (2021). Methodological aspects of oxygen gradient ektacytometry in sickle cell disease: Effects of sample storage on outcome parameters in distinct patient subgroups. Clinical Hemorheology and Microcirculation, 77(4), 391-394. https://doi.org/10.3233/CH-201037
Boisson C, et al. Methodological Aspects of Oxygen Gradient Ektacytometry in Sickle Cell Disease: Effects of Sample Storage On Outcome Parameters in Distinct Patient Subgroups. Clin Hemorheol Microcirc. 2021;77(4):391-394. PubMed PMID: 33361587.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Methodological aspects of oxygen gradient ektacytometry in sickle cell disease: Effects of sample storage on outcome parameters in distinct patient subgroups. AU - Boisson,Camille, AU - Rab,Minke A E, AU - Nader,Elie, AU - Renoux,Céline, AU - van Oirschot,Brigitte A, AU - Joly,Philippe, AU - Fort,Romain, AU - Stauffer,Emeric, AU - van Beers,Eduard J, AU - Sheehan,Vivien A, AU - van Wijk,Richard, AU - Connes,Philippe, PY - 2020/12/29/pubmed PY - 2021/5/22/medline PY - 2020/12/28/entrez KW - Oxygen gradient ektacytometry KW - red blood deformability KW - sickle cell disease KW - storage SP - 391 EP - 394 JF - Clinical hemorheology and microcirculation JO - Clin Hemorheol Microcirc VL - 77 IS - 4 N2 - Sickle cell disease (SCD) is a genetic disorder characterized by the production of an abnormal hemoglobin (Hb), which, under deoxygenation, may polymerize and cause a mechanical distortion of red blood cell (RBC) into a crescent-like shape. Recently a method, using ektacytometry principle, has been developed to assess RBC deformability as a function of oxygen tension (pO2) and is called oxygen gradient ektacytometry (oxygenscan). However, standardization of this test is needed to properly assess the tendency of sickling of RBCs under deoxygenation and to allow comparisons between different laboratories. The study compared the oxygenscan responses during blood storage between distinct populations of SCD patients. Blood from 40 non-transfused homozygous SCD patients (HbSS), 16 chronically transfused HbSS patients, and 14 individuals with compound heterozygous hemoglobin SC disease (HbSC) at steady-state was collected in EDTA tubes. Measurements were performed within 4 hours after collection and after 24 hours of storage at 4°C. We showed that storage affected the minimum RBC deformability reached during deoxygenation (EImin) in both non-transfused HbSS and HbSC patients and the maximum RBC deformability (EImax) measured before deoxygenation (i.e., in normoxia) in the three groups. In contrast, the tendency of RBCs to sickle under deoxygenation (i.e., the point of sickling; PoS) remained rather stable between the two time of measurements. Collectively, since the time between blood sampling and analysis affects some key oxygen gradient ektacytometry-derived parameters we recommend that each laboratory performs oxygenscan measurements at a standardized time point. SN - 1875-8622 UR - https://www.unboundmedicine.com/medline/citation/33361587/Methodological_aspects_of_oxygen_gradient_ektacytometry_in_sickle_cell_disease:_Effects_of_sample_storage_on_outcome_parameters_in_distinct_patient_subgroups_ DB - PRIME DP - Unbound Medicine ER -